Clinical Trial Update: An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitazoxanide for safety and efficacy in reducing collagen turnover in NASH patients with fibrosis; study completed with posted results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Cirrhosis of Liver
• Fatty Liver Disease
• Fibrosis of Liver
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Pinnacle Clinical Research, PLLC | Conditions: Non-alcoholic Steatohepatitis, Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2022-06-30